136 related articles for article (PubMed ID: 38836309)
1. Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.
Lott E; Fehlings D; Gelineau-Morel R; Kruer M; Mink JW; Thomas SP; Wisniewski S; Aravamuthan B;
Pediatrics; 2024 Jul; 154(1):. PubMed ID: 38836309
[No Abstract] [Full Text] [Related]
2. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy.
O'Flaherty S; Waugh MC
Hand Clin; 2003 Nov; 19(4):585-9. PubMed ID: 14596550
[TBL] [Abstract][Full Text] [Related]
4. Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey.
Smania N; Colosimo C; Bentivoglio AR; Sandrini G; Picelli A
Funct Neurol; 2013; 28(4):253-8. PubMed ID: 24598392
[TBL] [Abstract][Full Text] [Related]
5. Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report.
Roberts J; Tenaglia A; Bellissimo E; Kim H
J Pediatr Rehabil Med; 2024; 17(1):125-129. PubMed ID: 37522227
[TBL] [Abstract][Full Text] [Related]
6. Experience with botulinum toxin in the treatment of cerebral palsy.
Arens LJ; Leary PM; Goldschmidt RB
S Afr Med J; 1997 Aug; 87(8):1001-3. PubMed ID: 9323408
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy.
Reyes FI; Shoval HA; Tenaglia A; Kim H
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324655
[TBL] [Abstract][Full Text] [Related]
8. Management options for the child with spastic cerebral palsy.
Jacobs JM
Orthop Nurs; 2001; 20(3):53-9; quiz 59-61. PubMed ID: 12025635
[TBL] [Abstract][Full Text] [Related]
9. Role for botulinum toxin in back pain treatment in adults with cerebral palsy: report of a case.
Gallien P; Nicolas B; Petrilli S; Kerdoncuff V; Lassalles A; Le Tallec H; Durufle A
Joint Bone Spine; 2004 Jan; 71(1):76-8. PubMed ID: 14769528
[TBL] [Abstract][Full Text] [Related]
10. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
[TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin in the treatment of cerebral palsy--case conference].
Nezu A; Iai M
No To Hattatsu; 2010 May; 42(3):230-2. PubMed ID: 23858585
[No Abstract] [Full Text] [Related]
12. The role of intrathecal baclofen in the management of primary and secondary dystonia in children.
Woon K; Tsegaye M; Vloeberghs MH
Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454
[TBL] [Abstract][Full Text] [Related]
13. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
14. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
15. Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.
Blaszczyk I; Foumani NP; Ljungberg C; Wiberg M
Toxins (Basel); 2015 Nov; 7(11):4645-54. PubMed ID: 26561833
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.
Pin TW; Elmasry J; Lewis J
Dev Med Child Neurol; 2013 Apr; 55(4):304-13. PubMed ID: 23095013
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin-A for treatment of Pisa syndrome: A new target muscle.
Dupeyron A; Viollet E; Coroian F; Gagnard C; Renard D; Castelnovo G
Parkinsonism Relat Disord; 2015 Jun; 21(6):669-70. PubMed ID: 25899457
[No Abstract] [Full Text] [Related]
18. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?
Bradley LJ; Huntley JS
Arch Dis Child; 2014 Apr; 99(4):392-4. PubMed ID: 24626322
[No Abstract] [Full Text] [Related]
19. Use of botulinum toxin A in children with cerebral palsy.
Ross Raftemo AE; Mahendran A; Hollung SJ; Jahnsen RB; Lydersen S; Vik T; Andersen GL
Tidsskr Nor Laegeforen; 2019 May; 139(8):. PubMed ID: 31062563
[TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis after botulinum therapy in lower limb: A case report and literature review.
Mines ML; Pacheco T; Castel-Lacana E; de Boissezon X; Marque P; Montastruc F
Ann Phys Rehabil Med; 2019 Nov; 62(6):457-458. PubMed ID: 31707008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
